Early-Stage Lung Cancer With Severe COPD and Recent Coronary Stent
A 74-year-old man with a 50-pack-year smoking history presents with a 3.4 cm right upper lobe adenocarcinoma. PET/CT shows no mediastinal or distant uptake. Pulmonary function tests show FEV1 0.95 L (38% predicted) and DLCO 35% predicted; he becomes dyspneic after walking 50 meters. He has a drug-eluting stent placed 4 months ago and takes aspirin plus clopidogrel. Echocardiography shows LVEF 50% and no pulmonary hypertension. He wants “the cancer out” but is afraid of needing oxygen permanently. The thoracic oncology team asks for a surgical opinion.
1. What preoperative physiologic assessment is needed, and what resection would you recommend?
Read the worked answer
I would calculate predicted postoperative FEV1 and DLCO, obtain arterial blood gases, and use cardiopulmonary exercise testing if available; a VO2 max below about 10–12 mL/kg/min would substantially increase risk. I would also perform invasive mediastinal staging because the tumor is larger than 3 cm and occult nodal disease would change management. If staging is negative and physiology is acceptable, lobectomy with systematic nodal dissection remains oncologically preferred. If postoperative predicted values are marginal, sublobar resection-preferably anatomic segmentectomy-is a reasonable compromise for this peripheral tumor, provided margins and nodes can be adequately assessed. SBRT is an alternative if surgery is judged prohibitively risky. I would not promise avoidance of oxygen; I would explain that rehabilitation and lung preservation are priorities.
2. How do you manage the recent drug-eluting stent and dual antiplatelet therapy?
Read the worked answer
The stent is 4 months old, so elective surgery within the first 6 months carries a real stent-thrombosis risk if clopidogrel is stopped. I would involve cardiology and weigh cancer stage, symptoms, and bleeding risk. If the tumor is early-stage and surveillance is safe, delaying resection until 6 months after stenting is preferable. If delay is unacceptable, continue aspirin, stop clopidogrel 5 days before surgery, and avoid unnecessary transfusion; do not routinely bridge with heparin or glycoprotein inhibitors. Restart aspirin promptly after surgery and clopidogrel once bleeding risk is acceptable. If the patient cannot tolerate even a short DAPT interruption, a nonsurgical option such as SBRT should be discussed.
3. If EBUS shows a single-station N2 node, how does your recommendation change?
Read the worked answer
A single-station N2 finding changes this from upfront surgery to stage III disease requiring multidisciplinary planning. I would confirm the diagnosis with adequate tissue, assess the number and size of nodes, and consider brain MRI and PET restaging. For limited-volume N2 disease, options include neoadjuvant chemoradiation followed by surgery or definitive chemoradiation, depending on fitness and team expertise. For bulky or multistation N2 disease, definitive chemoradiation is generally preferred. I would not proceed directly to lobectomy outside a protocol. His poor pulmonary reserve also argues against extensive resection after high-dose radiation without careful reassessment.